The global Human Liver Models Market is projected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6%.

The human liver models market is emerging and fragmented in nature with various regional and international players. In 2016, the liver-on-a-chip and liver 3D bioprinting market was dominated by CN Bio (UK) and Organovo Holdings, Inc. (US), respectively.

Objectives of the Study

• To define, measure, and describe the global human liver model market by type and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW

For More Detailed Information, Feel Free to Connect to Our Research Experts

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global human liver model market and estimate the size of other dependent submarkets. Various secondary sources such as the Food and Drug Administration, Centers for Disease Control and Prevention, National Institute of Environmental Health Sciences, American Association for Clinical Chemistry, American Society for Biochemistry and Molecular Biology, American Society for Microbiology, International Federation of Pharmaceutical Manufacturers & Associations, Scientific Group on Methodologies for the Safety Evaluation of Chemicals, International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International, Society for In Vitro Biology, European Society for Animal Cell Technology, The British Association of Aesthetic Plastic Surgeons, UK Society for Cell Culture Biotechnology, directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

                                                          –> Global Industry Segmentation <–

The human liver model market is segmented on the basis of type and region. Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting.

In 2017, the animal models segment accounted for the largest share of the global market. The growth in the biosimilars market is expected to boost the preclinical market as the development of biosimilars and biopharmaceuticals requires an understanding of the mechanism of action, quantification of pharmacological effects, and interpretation of toxicological data.

You Can Also Request to Get 10% FREE Customization on This Report

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

The major players in the global human liver model market are Emulate (US), Ascendance Bio (US), HìREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).

Target Audience:

• Pharmaceutical and biotechnology companies
• Chemical companies
• Cosmetic product manufacturers, suppliers, and distributors
• Healthcare providers and diagnostic laboratories
• Manufacturers of 3D cell culture products
• Food & beverage manufacturers
• Contract research organizations (CROs)
• Research institutes/universities
• Research and consulting firms
• Venture capitalists